Benakli; Kamel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Benakli; Kamel.The latest application filed is for "macrocyclic ghrelin receptor modulators and methods of using the same".

Company Profile

1.16.12

Benakli; Kamel - Blue Bell PA
Benakli; Kamel - Bluebell PA US
Benakli; Kamel - Skippack PA
Benakli; Kamel - Montreal CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Macrocyclic ghrelin receptor modulators and methods of using the same Grant 10,258,602 - Hoveyda , et al.	2019-04-16
Macrocyclic Ghrelin Receptor Modulators and Methods of Using the Same App 20180228768 - Hoveyda; Hamid ; et al.	2018-08-16
Intermediates for macrocyclic compounds Grant 10,040,751 - Marsault , et al. August 7, 2	2018-08-07
Macrocyclic ghrelin receptor modulators and methods of using the same Grant 9,949,949 - Hoveyda , et al. April 24, 2	2018-04-24
Macrocyclic Ghrelin Receptor Modulators And Methods Of Using The Same App 20170042858 - Hoveyda; Hamid ; et al.	2017-02-16
Intermediates For Macrocyclic Compounds App 20160221927 - Marsault; Eric ; et al.	2016-08-04
Macrocyclic ghrelin receptor modulators and methods of using the same Grant 9,371,297 - Hoveyda , et al. June 21, 2	2016-06-21
Intermediates for macrocyclic compounds Grant 9,181,298 - Marsault , et al. November 10, 2	2015-11-10
Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders Grant 9,133,235 - Marsault , et al. September 15, 2	2015-09-15
Processes for intermediates for macrocyclic compounds Grant 8,497,242 - Marsault , et al. July 30, 2	2013-07-30
Spatially-defined macrocyclic compounds useful for drug discovery Grant 8,440,851 - Marsault , et al. May 14, 2	2013-05-14
Processes for Intermediates for Macrocyclic Compounds App 20110245459 - Marsault; Eric ; et al.	2011-10-06
Spatially-defined Macrocyclic Compounds Useful For Drug Discovery App 20110237785 - Marsault; Eric ; et al.	2011-09-29
Spatially-defined macrocyclic compounds useful for drug discovery Grant 8,022,252 - Deslongchamps , et al. September 20, 2	2011-09-20
Macrocyclic Antagonists Of The Motilin Receptor For Treatment Of Gastrointestinal Dysmotility Disorders App 20100093720 - Marsault; Eric ; et al.	2010-04-15
Intermediates For Macrocyclic Compounds App 20090240027 - Marsault; Eric ; et al.	2009-09-24
Macrocyclic Modulators of the Ghrelin Receptor App 20090198050 - Marsault; Eric ; et al.	2009-08-06
Spatially-defined Macrocyclic Compounds Useful For Drug Discovery App 20090137817 - Deslongchamps; Pierre ; et al.	2009-05-28
Macrocyclic antagonists of the motilin receptor Grant 7,521,420 - Fraser , et al. April 21, 2	2009-04-21
Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists Grant 7,452,862 - Deslongchamps , et al. November 18, 2	2008-11-18
Macrocyclic Ghrelin Receptor Modulators And Methods Of Using The Same App 20080194672 - Hoveyda; Hamid ; et al.	2008-08-14
Spatially-defined macrocyclic compounds useful for drug discovery App 20050137127 - Deslongchamps, Pierre ; et al.	2005-06-23
Macrocyclic antagonists of the motilin receptor App 20050054562 - Fraser, Graeme ; et al.	2005-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.